Genomic rearrangements in BRCA1 and BRCA2: A literature review

Genetics and Molecular Biology

Volumn 32, Issue 3, 2009, Pages 437-446

  Ewald, Ingrid Petroni ^a,b   Ribeiro, Patricia Lisboa Izetti ^a,b   Palmero, Edenir Inêz ^a,b   Cossio, Silvia Liliana ^a,b,c   Giugliani, Roberto ^a,b,c   Ashton Prolla, Patricia ^a,b,c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Instituto Nacional de Genética Médica Populacional INAGEMP   (Brazil)

Author keywords

BRCA1; BRCA2; Breast cancer; Genomic rearrangements; MLPA

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ALU SEQUENCE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CLINICAL PRACTICE; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC DIFFERENCE; GENETIC LINKAGE; GENETIC MARKER; GENETIC RISK; GENETIC SCREENING; HUMAN; INTERMETHOD COMPARISON; MASS SCREENING; MEDICAL LITERATURE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MULTIPLEX POLYMERASE CHAIN REACTION; OVARY CANCER; PROTEIN TRUNCATION TEST; PSEUDOGENE; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SHORT TANDEM REPEAT; SOUTHERN BLOTTING;

EID: 69949110747     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572009005000049     Document Type: Review

References (58)

1. Agata S, Dalla Palma M, Callegaro M, Scaini MC, Menin C, Ghiotto C, Nicoletto O, Zavagno G, Chieco-Bianchi L, D'Andrea E, et al. (2005) Large genomic deletions inactivate the BRCA2 gene in breast cancer families. J Med Genet 42:e64.
2. Armour JA, Barton DE, Cockburn DJ and Taylor GR (2002) The detection of large deletions or duplications in genomic DNA. Hum Mutat 20:325-337.
3. Barker DF, Liu X and Almeida ER (1996) The BRCA1 and 1A1.3B promoters are parallel elements of a genomic duplication at 17q21. Genomics 38:215-222.
4. Barrois M, Bièche I, Mazoyer S, Champème MH, Bressac-de Paillerets B and Lidereau R (2004) Real-time PCR-based gene dosage assay for detecting BRCA1 rearrangements in breast-ovarian cancer families. Clin Genet 65:131-136.
5. Bastard C, Raux G, Fruchart C, Parmentier F, Vaur D, Penther D, Troussard X, Nagib D, Lepretre S, Tosi M, et al. (2007) Comparison of a quantitative PCR method with FISH for the assessment of the four aneuploidies commonly evaluated in CLL patients. Leukemia 21:1460-1463.
6. Brown T (2001) Southern blotting. Curr Protoc Immunol Chapter 10: Unit 10.6A.
7. Brown MA, Xu CF, Nicolai H, Griffiths B, Chambers JA, Black D and Solomon E (1996) The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 12:2507-2513.
8. Bunyan DJ, Eccles DM, Sillibourne J, Wilkins E, Thomas NS, Shea-Simonds J, Duncan PJ, Curtis CE, Robinson DO, Harvey JF, et al. (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155-1159.
9. Casilli F, Di Rocco ZC, Gad S, Tournier I, Stoppa-Lyonnet D, Frebourg T and Tosi M (2002) Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments. Hum Mutat 20:218-226.
10. Chin SF, Wang Q, Puisieux A and Caldas C (2001) Absence of rearrangements in the BRCA2 gene in human cancers. Br J Cancer 84:193-195.
11. De Lellis L, Curia MC, Aceto GM, Toracchio S, Colucci G, Russo A, Mariani-Costantini R and Cama A (2007) Analysis of extended genomic rearrangements in oncological research. Ann Oncol 18(Suppl 6):173-178.
12. Dunnen den JT and White SJ (2006) MLPA and MAPH: Sensitive detection of deletions and duplications. Curr Protoc Hum Genet Chapter 7: Unit 7.14.
13. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689.
14. Gad S, Scheuner MT, Pages-Berhouet S, Caux-Moncoutier V, Bensimon A, Aurias A, Pinto M and Stoppa-Lyonnet D (2001) Identification of a large rearrangement of the BRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing. J Med Genet 38:388-392.
15. Gad S, Klinger M, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Bensimon A, Aurias A and Stoppa-Lyonnet D (2002) Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families. J Med Genet 39:817-821.
16. Gomez LC, Marzese DM, Adi J, Bertani D, Ibarra J, Mol B, Vos IJ, De Marchi G and Roqué M (2009) MLPA mutation detection in Argentine HNPCC and FAP families. Fam Cancer 8:67-73.
17. Gutierrez-Enriquez S, de la Hoya M, Martínez-Bouzas C, Sanchez de Abajo A, Ramón y Cajal T, Llort G, Blanco I, Beristain E, Díaz-Rubio E, Alonso C, et al. (2007) Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res Treat 103:103-107.
18. Hansen TV, Jonson L, Albrechtsen A, Andersen MK, Ejlertsen B and Nielsen FC (2009) Large BRCA1 and BRCA2 genomic rearrangements in Danish high breast - Ovarian cancer families. Breast Cancer Res Treat 115:69-76.
19. Hartmann C, John AL, Klaes R, Hofmann W, Bielen R, Koehler R, Janssen B, Bartram CR, Arnold N and Zschocke J (2004) Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 24:534.
20. Hauss O and Müller O (2007) The protein truncation test in mutation detection and molecular diagnosis. Methods Mol Biol 375:151-164.
21. Hendrickson BC, Judkins T, Ward BD, Eliason K, Deffenbaugh AE, Burbidge LA, Pyne K, Leclair B, Ward BE and Scholl T (2005) Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families. Genes Chromosomes Cancer 43:309-313.
22. Hofmann W, Gorgens H, John A, Horn D, Huttner C, Arnold N, Scherneck S and Schackert HK (2003) Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method. Hum Mutat 22:103-104.
23. Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, et al. (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63:1449-1453.
24. Kolomietz E, Meyn MS, Pandita A and Squire JA (2002) The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35:97-112.
25. Lahti-Domenici J, Rapakko K, Paakkonen K, Allinen M, Nevanlinna H, Kujala M, Huusko P and Winqvist R (2001) Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families. Cancer Genet Cytogenet 129:120-123.
26. Lim YK, Lau PT, Ali AB, Lee SC, Wong JE, Putti TC and Sng JH (2007) Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. Clin Genet 71:331-342.
27. Machado PM, Brandao RD, Cavaco BM, Eugenio J, Bento S, Nave M, Rodrigues P, Fernandes A and Vaz F (2007) Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: Evidence for a founder effect and analysis of the associated phenotypes. J Clin Oncol 25:2027-2034.
28. Mazoyer S (2005) Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 25:415-422.
29. Moisan AM, Fortin J, Dumont M, Samson C, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Pichette R, et al. (2006) No evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families. Genet Test 10:104-115.
30. Montagna M, Santacatterina M, Torri A, Menin C, Zullato D, Chieco-Bianchi L and D'Andrea E (1999) Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene 18:4160-4165.
31. Montagna M, Dalla PM, Menin C, Agata S, De NA, Chieco-Bianchi L and D'Andrea E (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12:1055-1061.
32. Morozova O and Marra MA (2008) From cytogenetics to next-generation sequencing technologies: Advances in the detection of genome rearrangements in tumors. Biochem Cell Biol 86:81-91.
33. Narod SA and Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4:665-676.
34. Nevanlinna H and Bartek J (2006) The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25:5912-5919.
35. Pavlicek A, Noskov VN, Kouprina N, Barrett JC, Jurka J and Larionov V (2004) Evolution of the tumor suppressor BRCA1 locus in primates: Implications for cancer predisposition. Hum Mol Genet 13:2737-2751.
36. Peelen T, van Vliet M, Bosch A, Bignell G, Vasen HF, Klijn JG, Meijers-Heijboer H, Stratton M, van Ommen GJ, Cornelisse CJ, et al. (2000) Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families. Br J Cancer 82:151-156.
37. Peixoto A, Salgueiro N, Santos C, Varzim G, Rocha P, Soares MJ, Pereira D, Rodrigues H, Bento MJ, Fráguas A, et al. (2006) BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families. Fam Cancer 5:379-387.
38. Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir Gilbert M and Mazoyer S (2002) The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNA bearing premature termination codons. Human Mol Genet 11:2805-2814.
39. Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drüsedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, et al. (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341-345.
40. Preisler-Adams S, Schonbuchner I, Fiebig B, Welling B, Dworniczak B and Weber BH (2006) Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer Genet Cytogenet 168:44-49.
41. Puget N, Stoppa-Lyonnet D, Sinilnikova OM, Pages S, Lynch HT, Lenoir GM and Mazoyer S (1999) Screening for germline rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 59:455-461.
42. Puget N, Gad S, Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM and Mazoyer S (2002) Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. Am J Hum Genet 70:858-865.
43. Ratajska M, Brozek I, Senkus-Konefka E, Jassem J, Stepnowska M, Palomba G, Pisano M, Casula M, Palmieri G, Borg A, et al. (2008) BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. Oncol Rep 19:263-268.
44. Rouleau E, Lefol C, Tozlu S, Andrieu C, Guy C, Copigny F, Nogues C, Bieche I and Lidereau R (2007) High-resolution oligonucleotide array-CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1. Clin Genet 72:199-207.
45. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F and Pals G (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57
46. Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L and King MC (1996) Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 6:1029-1049.
47. Staaf J, Törngren T, Rambech E, Johansson U, Persson C, Sellberg G, Tellhed L, Nilbert M and Borg A (2008) Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH). Hum Mutat 29:555-564.
48. Tancredi M, Sensi E, Cipollini G, Aretini P, Lombardi G, Di CC, Presciuttini S, Bevilacqua G and Caligo MA (2004) Haplotype analysis of BRCA1 gene reveals a new gene rearrangement: Characterization of a 19.9 kbp deletion. Eur J Hum Genet 12:775-777.
49. Thomassen M, Gerdes AM, Cruger D, Jensen PK and Kruse TA (2006) Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark. Cancer Genet Cytogenet 168:168-171.
50. Tournier I, Paillerets BB, Sobol H, Stoppa-Lyonnet D, Lidereau R, Barrois M, Mazoyer S, Coulet F, Hardouin A, Chompret A, et al. (2004) Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 64:8143-8147.
51. Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S and Weber BL (2000) Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67:841-850.
52. Vanin EF (1985) Processed pseudogenes: Characteristics and evolution. Annu Rev Genet 19:253-272.
53. Vasickova P, Machackova E, Lukesova M, Damborsky J, Horky O, Pavlu H, Kuklova J, Kosinova V, Navratilova M and Foretova L (2007) High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. BMC Med Genet 8:32.
54. Walsh T and King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103-105.
55. Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, et al. (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379-1388.
56. Wang T, Lerer I, Gueta Z, Sagi M, Kadouri L, Peretz T and Abeliovich D (2001) A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: A possible role of the Alu-polyA tail in the evolution of the deletion. Genes Chromosomes Cancer 31:91-95.
57. Weitzel JN, Lagos VI, Herzog JS, Judkins T, Hendrickson B, Ho JS, Ricker CN, Lowstuter KJ, Blazer KR, Tomlinson G, et al. (2007) Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 16:1615-1620.
58. Woodward AM, Davis TA, Silva AG, Kirk JA and Leary JA (2005) Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet 42:e31.